{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:35:47Z","timestamp":1768872947617,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002674","name":"Russian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["17-34-80125"],"award-info":[{"award-number":["17-34-80125"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"name":"scholarship of the President of the Russian Federation for young scientists and postgraduate students","award":["\u0421\u041f-2634.2016.4"],"award-info":[{"award-number":["\u0421\u041f-2634.2016.4"]}]},{"name":"CELSA\/17\/047 \u2013 BOF\/ISP"},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-14-00239"],"award-info":[{"award-number":["14-14-00239"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["17-74-10172"],"award-info":[{"award-number":["17-74-10172"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.neuropharm.2018.09.030","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T04:47:13Z","timestamp":1537591633000},"page":"228-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["KV1.2 channel-specific blocker from Mesobuthus eupeus scorpion venom: Structural basis of selectivity"],"prefix":"10.1016","volume":"143","author":[{"given":"Alexey I.","family":"Kuzmenkov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana V.","family":"Nekrasova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Peigneur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin M.","family":"Tabakmakher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei M.","family":"Gigolaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkady F.","family":"Fradkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kseniya S.","family":"Kudryashova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton O.","family":"Chugunov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman G.","family":"Efremov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey V.","family":"Feofanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander A.","family":"Vassilevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.09.030_bib1","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1016\/j.febslet.2006.10.029","article-title":"The first potassium channel toxin from the venom of the Iranian scorpion Odonthobuthus doriae","volume":"580","author":"Abdel-Mottaleb","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00594","article-title":"Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K(+) channel","volume":"2","author":"Banerjee","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib4","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2174\/0929866523666160630184635","article-title":"Scorpion toxin polyptides as therapeutic agents: an overview","volume":"23","author":"Bhavya","year":"2016","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jbt.20382","article-title":"ImKTx1, a new Kv1.3 channel blocker with a unique primary structure","volume":"25","author":"Chen","year":"2011","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib7","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1074\/jbc.M112.343996","article-title":"Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib8","doi-asserted-by":"crossref","first-page":"33112","DOI":"10.1038\/srep33112","article-title":"Temperature-sensitive gating of TRPV1 channel as probed by atomistic simulations of its trans- and juxtamembrane domains","volume":"6","author":"Chugunov","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib9","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1212\/WNL.0000000000003309","article-title":"Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy","volume":"87","author":"Corbett","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8100288","article-title":"Structural andfunctional elucidation of peptide Ts11 shows evidence of a novel subfamily of scorpion venom toxins","volume":"8","author":"Cremonez","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib10","series-title":"Venoms to Drugs: Venom as a Source for the Development of Human Therapeutics","first-page":"204","article-title":"CHAPTER 7. Scorpion venoms as a platform for drug development","author":"de la Vega","year":"2015"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1006\/bbrc.2001.5492","article-title":"OsK2, a new selective inhibitor of Kv1.2 potassium channels purified from the venom of the scorpion Orthochirus scrobiculosus","volume":"286","author":"Dudina","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib12","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1046\/j.1432-1327.2000.01577.x","article-title":"Chemical synthesis and characterization of Pi1, a scorpion toxin from Pandinus imperator active on K+ channels","volume":"267","author":"Fajloun","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/BSR20130052","article-title":"Functional evolution of scorpion venom peptides with an inhibitor cystine knot fold","volume":"33","author":"Gao","year":"2013","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cbpa.2011.03.027","article-title":"Molecular divergence of two orthologous scorpion toxins affecting potassium channels","volume":"159","author":"Gao","year":"2011","journal-title":"Comp. Biochem. Physiol. A. Mol. Integr. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib15","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.biochi.2010.08.003","article-title":"A potent potassium channel blocker from Mesobuthus eupeus scorpion venom","volume":"92","author":"Gao","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24762","article-title":"A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia","volume":"80","author":"Helbig","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-1119(89)90358-2","article-title":"Site-directed mutagenesis by overlap extension using the polymerase chain reaction","volume":"77","author":"Ho","year":"1989","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2016.10.004","article-title":"Scorpion toxin peptide action at the ion channel subunit level","volume":"127","author":"Housley","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejpn.2016.03.011","article-title":"Severe early-onset epileptic encephalopathy due to mutations in the KCNA2 gene: expansion of the genotypic and phenotypic spectrum","volume":"20","author":"Hundallah","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib20","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.apha.2017.01.004","article-title":"Sodium channels and venom peptide pharmacology","author":"Israel","year":"2017"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1110\/ps.8.8.1668","article-title":"Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused","volume":"8","author":"Kapust","year":"1999","journal-title":"Protein Sci."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib22","doi-asserted-by":"crossref","first-page":"27577","DOI":"10.1074\/jbc.272.44.27577","article-title":"Complex subunit assembly of neuronal voltage-gated K+ channels. Basis for high-affinity toxin interactions and pharmacology","volume":"272","author":"Koch","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib23","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1074\/jbc.M005973200","article-title":"An ERG channel inhibitor from the scorpion Buthus eupeus","volume":"276","author":"Korolkova","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib24","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1021\/jf070337l","article-title":"Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis","volume":"55","author":"Kuipers","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib25","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1134\/S0006297915130118","article-title":"Diversity of potassium channel ligands: focus on scorpion toxins","volume":"80","author":"Kuzmenkov","year":"2015","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib26","author":"Kuzmenkov"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bbapap.2017.02.001","article-title":"C-Terminal residues in small potassium channel blockers OdK1 and OSK3 from scorpion venom fine-tune the selectivity","volume":"1865","author":"Kuzmenkov","year":"2017","journal-title":"Biochim. Biophys. Acta \u2013 Proteins Proteomics"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib28","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1042\/BCJ20160436","article-title":"Lachesana tarabaevi, an expert in membrane-active toxins","volume":"473","author":"Kuzmenkov","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib29","doi-asserted-by":"crossref","first-page":"12195","DOI":"10.1074\/jbc.M115.637611","article-title":"Variability of potassium channel blockers in Mesobuthus eupeus scorpion venom with focus on Kv1.1: An integrated transcriptomic and proteomic study","volume":"290","author":"Kuzmenkov","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1124\/mol.113.090183","article-title":"Structure, molecular modeling, and function of the novel potassium channel blocker urotoxin isolated from the venom of the Australian scorpion Urodacus yaschenkoi","volume":"86","author":"Luna-Ram\u00edrez","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib31","doi-asserted-by":"crossref","first-page":"23616","DOI":"10.1074\/jbc.M115.656595","article-title":"Structural insight into specificity of interactions between nonconventional three-finger weak toxin from Naja kaouthia (WTX) and muscarinic acetylcholine receptors","volume":"290","author":"Lyukmanova","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib32","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1046\/j.1432-1033.2003.03743.x","article-title":"Synthesis and characterization of Pi4, a scorpion toxin from Pandinus imperator that acts on K+ channels","volume":"270","author":"M'Barek","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/bj20031860","article-title":"Diversity of folds in animal toxins acting on ion channels","volume":"378","author":"Mouhat","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jbiotec.2016.11.030","article-title":"Straightforward approach to produce recombinant scorpion toxins-Pore blockers of potassium channels","volume":"241","author":"Nekrasova","year":"2017","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/17460441.2017.1317243","article-title":"Enhancing the therapeutic potential of peptide toxins","volume":"12","author":"Norton","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2017.07.002","article-title":"Venom-derived peptide inhibitors of voltage-gated potassium channels","volume":"127","author":"Norton","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1006\/bbrc.1997.8018","article-title":"Pandinus imperator scorpion venom blocks voltage-gated K+ channels in human lymphocytes","volume":"242","author":"P\u00e9ter","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib38","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/bioinformatics\/btp111","article-title":"PLATINUM: a web tool for analysis of hydrophobic\/hydrophilic organization of biomolecular complexes","volume":"25","author":"Pyrkov","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxicon.2017.01.014","article-title":"Venom-gland transcriptomics and venom proteomics of the black-back scorpion (Hadrurus spadix) reveal detectability challenges and an unexplored realm of animal toxin diversity","volume":"128","author":"Rokyta","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/toxins8120367","article-title":"Venom gland transcriptomic and proteomic analyses of the enigmatic scorpion superstitionia donensis (scorpiones: superstitioniidae), with insights on the evolution of its venom components","volume":"8","author":"Santib\u00e1\u00f1ez-L\u00f3pez","year":"2016","journal-title":"Toxins (Basel)."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib41","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1074\/jbc.M111.329607","article-title":"New tricks of an old pattern: structural versatility of scorpion toxins with common cysteine spacing","volume":"287","author":"Saucedo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib42","doi-asserted-by":"crossref","first-page":"30040","DOI":"10.1074\/jbc.M111258200","article-title":"kappa-Hefutoxin1, a novel toxin from the scorpion Heterometrus fulvipes with unique structure and function. Importance of the functional diad in potassium channel selectivity","volume":"277","author":"Srinivasan","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng.3239","article-title":"De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy","volume":"47","author":"Syrbe","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0165-6147(99)01398-X","article-title":"A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies","volume":"20","author":"Tytgat","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/mol.112.078006","article-title":"Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells","volume":"82","author":"Varga","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bcp.2014.12.002","article-title":"Mesomartoxin, a new Kv1.2-selective scorpion toxin interacting with the channel selectivity filter","volume":"93","author":"Wang","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib47","doi-asserted-by":"crossref","first-page":"5.6.1","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib48","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nrd2983","article-title":"Voltage-gated potassium channels as therapeutic targets","volume":"8","author":"Wulff","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.09.030_bib49","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbapap.2009.12.017","article-title":"MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity","volume":"1804","author":"Zhu","year":"2010","journal-title":"Biochim. Biophys. Acta \u2013 Proteins Proteomics"},{"key":"10.1016\/j.neuropharm.2018.09.030_bib50","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.002832","article-title":"Molecular diversity and functional evolution of scorpion potassium channel toxins","volume":"10","author":"Zhu","year":"2011","journal-title":"Mol. Cell. Proteomics"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T01:36:11Z","timestamp":1543282571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818306919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":51,"alternative-id":["S0028390818306919"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.030","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KV1.2 channel-specific blocker from Mesobuthus eupeus scorpion venom: Structural basis of selectivity","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}